Form 4: AtriCure CEO Michael Carrel Donates 3,000 Shares to Charity
SEC Form 4 Filing
AtriCure's CEO, Michael Carrel, reported a charitable gift of 3,000 common stock shares and disclaims beneficial ownership of shares held by his children and parents.
Summary
- On August 14, 2024, Michael H. Carrel, the President, CEO, and Director of AtriCure, Inc., made a charitable gift of 3,000 shares of AtriCure common stock.
- No consideration was received for this donation.
- Following the transaction, Carrel directly owns 653,239 shares of AtriCure common stock.
- Carrel also disclaims beneficial ownership of 5,310 shares held by his children and 2,250 shares held by his parents, except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing simply reports a charitable donation by the CEO, which doesn't inherently indicate positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect a strategic shift or material event for AtriCure within the broader medical device industry.
Stakeholder Impact
- The charitable donation has a negligible impact on shareholders.
- The donation has no impact on employees, customers, suppliers or creditors.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of charitable gift transaction |
| 08/16/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.